Andere Sprachen ORION Corp.

Aktien

A271560

KR7271560005

A271560

Schlusskurs Korea S.E. Andere Börsenplätze 00:00:00 07.05.2024			% 5 Tage	% 1. Jan.
93.400 ^KRW	+0,43 %		-0,11 %	-19,55 %

13.03.	ORION Corp. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
2023	ORION Corp. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ORION Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	13.03.
Orion Set to Acquire 25% Stake in LegoChem Biosciences	17.01.
Orion Temporarily Resumes Production of Discontinued Snacks to Offer Young Patients	10.01.
ORION Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
Celcuity to Proceed With Phase 1b/2 Trial of Gedatolisib Plus Nubeqa, Signs Supply Agreement With Bayer	22.08.23
ORION Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14.08.23
Marinus Pharmaceuticals Says European Commission Approves Ztalmy Oral Suspension	31.07.23
Orion Corporation Announces European Commission Approval of Ztalmy(R) for the Adjunctive Treatment of Epileptic Seizures Associated with CDKL5 Deficiency Disorder	31.07.23
ORION Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	15.05.23
Orion Corporation and Amneal Pharmaceuticals, Inc. Sign License Agreement with Amneal Pharmaceuticals, Inc. to Commercialise Amneal's Generic Products in Europe, Australia and New Zealand	04.01.23
South Korean Snack Maker Orion Temporarily Closes Tmall Flagship Store	27.12.22
Orion Results from an Ongoing Phase I/II CYPIDES Trial of ODM-208 Presented at ASCO-GU	18.02.22
Infosys Selected by Finland-Based Orion to Help Transform Its ERP, Planning Platforms	14.12.21
Orion's Net Attributable Income Declines 4.3% in September Quarter	11.11.21
Marinus Pharmaceuticals Submits NDA to FDA for Seizure Treatment	03.08.21
China's Economy Powers Ahead While the Rest of the World Reels	13.01.21
Les actions hésitantes, la Chine et les résultats en soutien	09.07.20
Lotus Pharma and Orion to Enter into Marketing and Distribution Agreement	31.12.19
Oriola and Orion Renew Their Distribution Agreement in Finland	28.08.19
AVIS D'ANALYSTES DU JOUR : Société Générale, Airbus, Publicis, Peugeot, Unilever	20.07.18

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ORION Corp.

Aktien

A271560

KR7271560005

A271560

Andere Sprachen

Filter